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Abstract. Our understanding of lympho-hematopoietic 
microenvironments is incomplete, and a new cloning 
strategy was developed to identify molecules that bind 
to B lineage lymphocyte precursors. A cell sorting pro- 
cedure was used for initial enrichment of cDNAs from 
stromal cell mRNA that contained signal sequences 
and were therefore likely to encode transmembrane or 
secreted proteins. A second step involved expression of 
the library as soluble Ig fusion proteins. Finally, pools 
representing these proteins were screened for the abil- 
ity to recognize pre-B cells. This approach resulted in 
the cloning of biglycan, syndecan 4, collagen type I, 
clusterin, matrix glycoprotein scl, osteonectin, and one 
unknown molecule (designated SIM). The full-length 
cDNA of SIM revealed that it is a type I transmem- 
brane protein, and its intraceUular domain has weak 
homology with myosin heavy chain and related pro- 
teins. Staining of established cell lines and freshly iso- 
lated hematopoietic cells with the Ig fusion proteins re- 
vealed distinct patterns of reactivity and differential 
dependence on divalent cations. Biglycan-, scl-, and 
SIM-Ig fusion proteins selectively increased interleu- 
kin 7-dependent proliferation of pre-B cells. Overex- 
pression of the entire SIM protein affected the mor- 
phology of 293T cells, while expression of just the 
extracellular portion was without effect. Thus, a series 
of stromal cell surface molecules has been identified 
that interact with blood cell precursors. Three of them 
promoted the survival and/or proliferation of pre-B 
cells in culture, and all merit further study in relation to 
lympho-hematopoiesis. 
LOOD cell formation is highly dependent on complex 
interactions between stromal and hematopoietic 
cells (23). Multiple cell types transiently interact 
within a confined space in bone marrow to deliver and to 
receive critical signals for proliferation and differentiation. 
In addition, the movement of cells within, and egress from, 
this microenvironment is carefully linked to their matura- 
tion (1). It is important to identify cell surface molecules 
that mediate these interactions. Information already avail- 
able suggests that several major categories of proteins are 
involved. 
The extracellular matrix in bone marrow is not merely 
an inert framework; it also mediates specialized functions 
(33, 62). For example, it can bind many growth factors and 
cell surface  glycoproteins.  Characterization of substances 
made by stromal cells revealed that the matrix includes 
collagens, laminin, fibronectin, and a variety of proteogly- 
can species.  Laminin is a major protein in basal  lamina 
that can bind heparan sulfate, type IV collagen, and also 
cell surface receptor proteins. Fibronectin promotes mi- 
gration and adhesion of many cells. Proteoglycans can at- 
tach to cell surfaces where they facilitate cell-matrix inter- 
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actions. Hyaluronan forms viscous and hydrated gels, and 
in several  systems,  facilitates  cell-cell adhesion and cell 
migration. 
The large integrin superfamily of adhesion molecules in- 
cludes many potential ligands for matrix molecules  (15). 
Particular integrins on lympho-hematopoietic progenitors 
and stromal cells play an important role in hematopoiesis 
(23).  Pre-B  cells  could be  displaced  from the  adherent 
layer of long-term bone marrow cultures by addition of 
antibodies to  a4  or  (vascular  cell  adhesion molecule  1 
(VCAM-1),  and these reagents completely blocked lym- 
phopoiesis  in long-term bone marrow cultures (43, 44). 
While ligation of integrins can deliver signals for survival, 
growth, and differentiation, interactions between very late 
antigen (VLA)  a 5 and fibronectin cause apoptosis  in cer- 
tain hematopoietic cell lines (58). 
Multiple isoforms of CD44 constitute another family of 
cell adhesion molecules,  and one of their ligands is hyalu- 
ronan (32). Antibodies to CD44  completely blocked the 
production of lymphoid and myeloid cells in long-term 
bone marrow cultures (42). Although most blood cells ex- 
press CD44, only subpopulations actually use it to recog- 
1.  Abbreviations  used in  this paper.  IL, interleukin; PE,  phycoerythrin; 
RT, reverse transcriptase; VLA, very late antigen. 
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glycosylation  of  CD44  (18,  30).  Interactions  between 
CD44 and hyaluronan are important in extracellular ma- 
trix formation and for cell migration (26, 62). 
Regulatory cytokines in the bone marrow microenviron- 
ment represent a final category and are essential for repli- 
cation and differentiation  of blood cell precursors (22, 33, 62). 
These factors are typically made in extremely small quan- 
tities, and some of them, such as interleukin (IL) 7 (IL7), 
IL3, and granulocyte-macrophage colony stimulating fac- 
tor (G/M-CSF), are capable of attachment to the extracel- 
lular matrix. Certain other cytokines, such as macrophage 
colony stimulating factor and stem cell factor, are synthe- 
sized as transmembrane, as well as soluble, forms. 
A  number of experimental approaches have been used 
to  implicate  matrix molecules, cell  adhesion  molecules, 
and cytokines in blood cell formation, and there are ad- 
vantages and limitations to each (23).  While mAbs have 
been  extensively and  effectively exploited,  highly con- 
served molecules may not be immunogenic. Furthermore, 
it can be  difficult to prepare  antibodies that block, and 
thus define, important functions. An alternative approach 
is suggested by the fact that a signal sequence is present 
during biosynthesis of most extracellular proteins, includ- 
ing type I transmembrane proteins and cytokines. Signal 
sequence trap methods exploit this fact to clone genes for 
such proteins (55, 59). 
We established a new cloning strategy for identifying ei- 
ther cell surface or soluble molecules with the ability to 
recognize hematopoietic cells. A previously described sig- 
nal sequence trap method (59) was modified and used for 
initial  enrichment  of  cDNAs  encoding  transmembrane 
and  secreted  proteins.  Pools  from this  enriched  library 
were then expressed as soluble Ig fusion proteins, which 
were  subsequently screened  for  binding  to  pre-B  cells. 
This method allowed us to identify six extracellular matrix 
components and one previously unknown type I cell sur- 
face  molecule. Furthermore,  initial experiments  suggest 
that  some  of these  proteins  might function to  regulate 
blood cell formation. 
Materials and Methods 
Cells 
BCB8, BCB9, and BCB10 pre-B cell clones were established from nonad- 
herent cells of Whitlock-Witte-type long-term cultures that had been pre- 
pared from BALB/c bone marrow cells. These lymphocytes were main- 
tained  in  McCoy's  5A  medium  (GIBCO  BRL,  Gaithersburg,  MD) 
supplemented with 5% FCS (GIBCO BRL) and 5 x  10 -5 M 2-mercapto- 
ethanol in the presence of 1 ng/ml IL7 (R&D Systems, Minneapolis, MN) 
and 10 ng/ml stem cell factor (Amgen, Thousand Oaks, CA). Cloned OP42 
stromal cells were established using adherent spleen cells from osteope- 
trotic OP/OP B6C3fe mice (56). They lack the capacity to synthesize mac- 
rophage colony stimulating factor (M-CSF) and efficiently support the 
growth of B lymphocyte precursors when exogenous IL7 is added. These 
cells were maintained in DME supplemented with 10% FCS and 5 ×  10  -s 
M  2-mercaptoethanol. Lymphoma cell lines (707_/3,  WEHI231,  AKR1, 
EL4), a  B cell hybridoma (BM2), an erythroleukemia cell line (GM86), 
myelo-macrophage cell lines (WEHI3, P388D1), stromal cell lines (BMS2, 
ST2),  fibroblast cell lines (NIH3T3,  L), a  melanoma cell line (B16F10), 
and a neuroblastoma cell line (N2A) were maintained as previously de- 
scribed (43).  COS, an SV-40--transformed African green monkey kidney 
cell line, and 293T,  a  human renal carcinoma cell line transfected with 
large T antigen, were maintained in DME supplemented with 10% FCS. 
Plasmids 
To make NotI and Xhol sites, two oligonucleotides, 5'-CTCTAGATCT- 
GCGGCCGCTGACTAACTGACCTCGAGG  and  5'-GATCCCTCG- 
AGGTCAGTFAGTCAGCGGCCGCAGATCTAGAGGTAG,  were an- 
nealed and ligated into KpnI and BamHI sites of pBluescript KS to yield 
pBSKNotI/XhoI. To make the HPCA epitope tag sequence, two oligonu- 
cleotides, 5'-TCGAGAGAAGATCAGGTAGATCCGCGGTTAATCG- 
ATGGTAAGATI'GAAGGAAGGG  and  5'-AATTCCCTTCCI'TCA- 
ATCTTACCATCGATrAACCGCGGATCTACCTGATCITCTC,  were 
annealed and ligated into XhoI and EcoRl sites of pBluescript KS (HPC4/ 
pBSK) (50).  A  plasmid containing the transmembrane domain of tissue 
factor (pJH93; donated by Dr. J.H. Morrissey, Oklahoma Medical Re- 
search Foundation, Oklahoma City, OK) was digested with EcoRI and 
BamHI before ligation into HPC4/pBSK (HPC4-TF/pBSK).  HPC4-TF/ 
pBSK was used as a template for PCR by two primers, 5'- CGCGGATC- 
CGGAAGATCAGGTAGATCCGCGG  and  5'-CGCAGATCTAAGC- 
TTACTTGTGTAGAGA.  This PCR product was digested with BamHI 
and Bglll and ligated into the BamHI site of pBSKNotl/Xhol (HPC4-TF/ 
pBSKNotI/XhoI). The pEFBOS vector (45)  (a kind gift from Dr. S. Na- 
gata, Osaka Bioscience Institute, Osaka, Japan) was modified by site-di- 
rected mutagenesis to remove the XhoI site at 3524, yielding pEFBOSX. 
This plasmid was then used as a recipient for the insert sequence of HPC4- 
TF/pBSKNotl/XhoI  by  using  an  Xbal  site  (HPC4-TF/pEFBOSX).  A 
cDNA of CH2 and CH3 domains of human IgG1 was digested at BamHI 
and BgllI sites of the CD8-IgG1 vector (2) (generously provided by Dr. A. 
Aruffo, Bristol-Meyers Squibb)  and  ligated into  a  BamHI  site of pB- 
SKNotI/XhoI (Ig/pBSKNotI/XhoI). The insert sequence of Ig/pBSKNotI/ 
XhoI was cut and ligated into the pEFBOSX vector by using an XbaI site 
(Ig/pEFBOSX). All constructs were confirmed by sequencing. The HPC4- 
TF/pEFBOSX vector was used for the signal sequence trap method. The 
Ig/pEFBOSX vector was used for producing Ig fusion proteins. 
Stromal Cell cDNA Library 
A cDNA library was made by converting poly (A) ÷ RNA (5 p,g) of OP42 
stromal cells to cDNA with the use of random primers and SuperScript  ® 
reverse transcriptase (GIBCO BRL). A dC tail was then added to the cDNAs 
at the 3' end with terminal deoxynucleotidyl transferase (GIBCO BRL). 
The second strands were synthesized by priming with 5' GGTACCGCG- 
GCCGCTGACTAACTGAC-(dG)17,  which contained a  NotI linker and 
oligo dG. After sonication, DNA fragments >250  bp were isolated by 
electrophoresis in a 1% agarose gel. After blunting, the XhoI adaptors 5'- 
CCGCCTCGAGGATATCAAGCITGTAC and 3'-GGCGGAGCTCCT- 
ATAGTTCGAACATGGAG were ligated. The fragments were then am- 
plified by PCR with two primers, 5'-GGTACCGCGGCCGCTGACTAA- 
CTGACG  and 5'-GAGGTACAAGCTTGATATCCTCGAGGCGG.  15 
cycles of PCR reaction (94"C for 1 min, 55°C for 2 min, and 72°C for 3 
min)  were done with a  thermal  cycler (Perkin-Elmer/Cetus, Norwalk, 
CT). Amplified DNA fragments were digested with NotI and XhoI and li- 
gated into NotI and XhoI sites of the HPC4-TF/pEFBOSX vector. 
Enrichment of  cDNAs Carrying Signal Sequences 
A positive control CD44 (5') fragment including a signal sequence was ob- 
tained by NotI  and XhoI digestion of PCR  samples of the pMCD44/ 
TCFMo plasmid (31)  template with two primers, 5'-GGGGCGGCCG- 
CACGCCATGGACAAG'IqT and 5'-CGCCTCGAGTC'TGGAATCT- 
GAGGTCTC. A negative control BCL2 (5') fragment that does not have 
a signal sequence was obtained by NotI and XhoI digestion of PCR sam- 
ples of the pKSBcl2 plasmid template with two primers, 5'-GGGGCGG- 
CCGCACTCGGGACTTGAAGTGCCATI'GG  and 5'-GGGCTCGAG- 
GGAGACTGCCTGGCAGCCATCTCC.  Both fragments were ligated 
into NotI and XhoI sites of the HPC4-TF/pEFBOSX vector. 
The cDNA library contained in the HPC4-TF/pEFBOSX vector was 
transfected to Escherichia  coli, and plasmid DNAs from all (~3  ×  105) 
colonies were prepared. Pooled plasmid DNAs (20 ~g) were then trans- 
fected into 5 ×  106 COS cells by electroporation (250 V, 500 ~F) using a 
gene pulser (Bio Rad Laboratories, Hercules, CA). The COS cells were 
stained with the HPC4 antibody and fluorescein-conjugated goat anti- 
mouse Ig 2 d after transfection, and cells that expressed the HPC4 epitope 
tag on their surface were collected by cell sorting. The plasmid DNAs 
were recovered from sorted cells by Hirt's method (14). For enrichment of 
cDNAs carrying signal sequences, this process was repeated three times. 
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Plasmids from the signal sequence-enriched library were digested with 
Notl and XhoI, and then DNA fragments were isolated by gel electro- 
phoresis and ligated into NotI and XhoI sites of Ig/pEFBOSX vector. Af- 
ter transformation of E.  coli,  900 individual colonies were  picked,  and 
pools containing 10 colonies each were prepared.  Plasmid DNAs from 
each  pool  were  transfected  into  293T  cells with  a  calcium phosphate 
method. 4 d after the transfection, supernatants were harvested from each 
sample. BCB10 cells were then stained with these supernatants and fluo- 
rescein-conjugated goat anti-human IgG (Southern Biotechnology Asso- 
ciates, Birmingham, AL). After identification of a positive pool, each clone 
of that pool was rescreened. The nucleotide sequence of each cloned in- 
sert was determined by using a  Sequenase version 2.0 DNA sequencing 
kit (United States Biochemical Corp., Cleveland, OH). Nucleofide data- 
base searching was then performed with FASTA and BLAST from the 
GCG computer program (Genetics Computer Group, Madison, WI). 
Cloning of Full-Length 4-9 cDNA 
To  perform PCR,  sense and  antisense primers, 5'-GGTGTCTACAG- 
CAGGCGCATI'GTTG  and 5'-GGTCITCCCITAGGAACTCATCAC, 
were designed from the 5' portion eDNA insert sequence of 4-9. As BMS2 
stromal cells also express this gene, a eDNA library was made in the pEF- 
BOS vector from mRNA of BMS2 cells using oligo dT and a TimeSaver 
cDNA synthesis kit (Pharmacia, Uppsala, Sweden). Suspensions of pools 
containing several thousand colonies were  subjected to  PCR  reactions 
with the above two primers. After 35 cycles of PCR reaction (94°C for 1 
rain, 55°C for 2 min, and 72°C for 3 min), PCR samples were separated in 
1.5% agarose gels and screened with a specific amplified band (327 bp). A 
positive pool was divided into progressively smaller pools and rescreened 
until a single clone was isolated. The insert of a single clone was subcloned 
into pBluescript, and the nucleotide sequence was determined using an 
automated DNA sequencer (Applied Biosystems, Foster City, CA). 
Flow Cytometry Analysis 
Antibody incubations and washing steps were perfomed at room tempera- 
ture in HBSS (GIBCO BRL) containing 1% BSA (Sigma Chemical Co., 
St. Louis, MO) and 0.1% sodium azide, or in 10 mM Tris-HC1 saline con- 
taining 1% bovine albumin, 0.1% sodium azide, and 5 mM MnCI  2. Cells 
were  analyzed with a  FACScan  ® flow eytometer (Becton Dickinson & 
Co., Mountain View, CA). Potential binding to Fc-,/II and Fe,/III receptors 
was blocked in some experiments by addition of the 2AG2 mAb (61). As 
another means of minimizing possible recognition of Fc receptors, a mu- 
tated CH2 +  CH3 cassette of human IgG1 (37), obtained from Dr. Peter 
Linsley (Bristol-Myers Squibb), was used for expression of soluble Ig fu- 
sion proteins in some experiments. Supernatants of cultures of 293T cells 
transfected with the Ig/pEFBOSX  vector,  as well  as soluble CD44-Ig, 
CD73-Ig, and CD7-Ig fusion proteins, were used as negative controls. 
Antibodies used in this study were as follows: phycoerythrin (PE)-conju- 
gated anti-mouse CD45RA from Pharrningen (San Diego, CA); FITC- 
conjugated anti-mouse Mac1 from Boehringer Mannheim Biochemicals 
(Indianapolis, IN); PE-conjugated anti-mouse IgM and FITC- or PE-con- 
jugated goat F(ab')2 anti-human IgG (mouse adsorbed); and FITC-conju- 
gated goat anti-human IgG from Southern Biotechnology Associates. 
Reverse Transcriptase (RT)-PCR 
Total RNAs were isolated by the method of Chomzynski and Sacchi (5). 
Total RNA (5 p~g) was reverse transcribed to cDNA in a  total reaction 
volume of 20  ~l  comprised  of  Moloney  leukemia virus reverse  tran- 
scriptase (Promega, Madison, WI), oligo dT (0.5 p~g), 0.1 M DTT, 10 mM 
each dNTP, and 1× RT buffer. The RT mixes were incubated at 39°C for 
2 h followed by 10 min at 90°C.  To perform PCR reactions, 2 p~l of the 
above RT mixtures were added to PCR buffer containing MgC12 (1.5 raM), 
Taq polymerase (1 U; Promega), dNTP (2 mM each), and relevant sense 
and antisense primers to a total volume of 100 Ixl. PCR reaction mixtures 
were amplified by using 30 cycles under the following conditions: 94°C for 
I min, 55°C for 2 min, and 72°C for 3 min in a thermal cycler. PCR samples 
(15  p.l) were electrophoresed in 1.5%  agarose gels containing 0.5 ixg/ml 
ethidium bromide. Products were visualized under UV illumination. The 
oligonucleotide primers used for these reactions were as follows: 
Biglycan 
Syndecan 4 
Collagen I 
Clusterin 
Osteonectin 
scl 
4-9 
I~-Actin 
Sense:TACCTFCAGTGCCATGTGTCCT 
Antisense:CTGGTTCAAAGCTGTTCTCC 
Sense:CCGCTGCTGCTGCTGCTCCTCGGA 
Antisense:GCA'ITCTCAGGGATCTG  GTTATCC 
Sense:GTC'ITACI~GGGAACYVI'G  CTGCTC 
Antisense:GCCAACGCTTCCATCACTGCCI~CG 
Sense:AGCTCCAAGAACTGTCCACTCAAG 
Antisense:GACATGAGGCTGCGGACCAAGCGG 
Sense:AGACTGAAGTI'GCTGAGGAGATAG 
Antisense:AGAGGGAATTCGGTCAGCTCGGAA 
Sense:CTTCAAGCTACCAAGGCTCTGGAT 
Antisense:CCTGCTCTGTTGACTGTI'CATGAG 
Sense:GGTGTCTACAGCAGGCGCATFGT]?G 
Antisense:GGTCTTCCCTFAGGAACTCATCAC 
Sense:CCTAAGGCCAACCGTGAAAAG 
Antisense:TCTI~CATGGTGCTAGGAGCCA 
Northern Blot Analysis 
A  blot containing 2 ~g of poly(A) + RNAs from adult mouse tissues was 
acquired from Clontech (Palo Alto, CA). The 4-9- and I~-actin-containing 
eDNA fragments were labeled with [a-32p]dCTP using a random primed 
DNA labeling kit (Boehringer Mannheim Biochemicals) and hybridized 
to the membrane overnight at 42°C. Blots were then washed and autora- 
diographed. 
Colony-forming Cell  Assay 
For the enrichment of B lymphocyte lineage cells, bone marrow cells from 
6-8-wk-old BALB/c mice were incubated in mAb 14.8 (CD45RA, a pan B 
lineage marker) coated petri dishes for 40 rain at 4°C as in our previous 
studies (40). After nonbinding cells were washed off, bound cells were re- 
covered  by  pipetting.  Whole  bone  marrow  cells  or  the  lymphocyte- 
enriched cells were suspended in 1 ml of assay medium, and the semisolid 
agar colony assay for B lymphocyte precursors (CFU-IL7) was performed 
with 1 ng recombinant mouse IL7. The granulocyte-macrophage progeni- 
tor assay (CFU-c) was similarly performed with 25 ILl of 10-fold concen- 
trated WEHI3 conditioned medium. All colony assays were perfomed in 
35-mm dishes and incubated at 37°C, 5% CO2. Numbers of colonies were 
counted on day 6. The fusion proteins used in titration experiments (see 
Fig.  6)  were  purified  on  protein  A-bearing  affinity  columns  (Pierce 
Chemical Co., Rockford, IL). 
Results 
Successful Enrichment of cDNAs Containing 
Signal Sequences 
Signal  sequence  trap  procedures  previously  have  been 
used  to  identify  cDNAs  for  extracellular  or  transmem- 
brane  proteins  (59),  and  we  now  demonstrate  that  a 
cDNA library can be enriched on this basis. The HPC4- 
TF/pEFBOSX vector was constructed with NotI and XhoI 
cloning sites positioned between a human EF-let promoter 
and coding sequences for the HPC4 epitope tag and the 
transmembrane domain of tissue factor (Fig. 1 A). When 
inserts  with  signal  sequences  were cloned  in-frame with 
the correct orientation, fusion proteins were expressed on 
mammalian cells and detected by an antibody to the HPC4 
epitope  tag.  In  contrast,  when  inserts  lacked  signal  se- 
quences or were cloned out-of-frame, the fusion proteins 
remained  intracellular.  The  effectiveness  of this  system 
was evaluated with a 5' cDNA fragment of CD44 contain- 
ing  a  signal  sequence  as  a  positive  control.  The  HPC4 
epitope tag appeared on the surface of 293T cells trans- 
fected with  CD44-HPC4-TF/pEFBOSX  (Fig.  1 B).  A  5' 
cDNA fragment of BCL2  that  lacked a  signal  sequence 
was  used  as  a  negative  control,  and  transfection  with 
BCL2-HPC4-TF/pEFBOSX  did  not  direct  an  epitope- 
tagged protein to the cell surface. 
Oritani and Kincade Stromal Cell Interaction Molecules  773 Figure 1.  Enrichment of cDNAs containing  signal sequences  by 
repeated cycles of transfection  and cell sorting.  (A) The HPC4- 
TF/pEFBOSX vector was used for enrichment of cDNAs carry- 
ing  signal  sequences.  (B)  Negative  control  (BCL2-HPC4-TF/ 
pEFBOSX), positive control (CD44-HPC4-TF/pEFBOSX),  and 
cDNA-containing  plasmids  from different stages of the enrich- 
ment (library  before and after sorting three times) were trans- 
fected into 293T cells using a Ca  ++ phosphate method. The trans- 
fected cells  were then stained  with  an  antibody to the  HPC4 
epitope tag. Shaded histograms depict staining obtained with the 
HPC4 mAb, and open histograms represent results obtained with 
the second antibody alone. 
This vector was used to prepare a  cDNA library from 
the OP42 stromal cell clone, and the average size of the in- 
serts was 400 bp (range 250--600 bp). We transfected the li- 
brary into COS cells and recovered plasmids from HPC4- 
positive cells that had been isolated by cell sorting. This 
procedure was repeated three times. The effectiveness of 
enrichment was monitored by flow cytometry and is illus- 
trated in Fig. 1 B. Transfectants prepared from the repeat- 
edly sorted library showed much higher expression of the 
HPC4 epitope tag than transfectants made with the origi- 
nal stromal cell cDNA library. Therefore, we successfully 
designed a system for enrichment of cDNA fragments that 
include sequences for signal peptides. 
Isolation of Clones Whose Ig Fusion Proteins Recognize 
a Pre-B Cell Line 
cDNAs  that  have  been  enriched  for  signal  sequences 
would correspond to a host of proteins, and a second step 
Figure 2.  Recognition  of a pre-B cell line, BCB10, by Ig fusion 
proteins.  (A) The Ig/pEFBOSX vector was used to produce Ig fu- 
sion proteins. Each cloned plasmid and a control plasmid (CD44- 
Ig/pEFBOSX) were transfected into 293T cells. (B) BCB10 cells 
were then stained  with supernatants from each transfected sam- 
ple, followed by FITC-goat anti-human IgG (shaded  histograms). 
HBSS containing  1% BSA and 0.1% azide was used as washing 
buffer. Control staining obtained with the second antibody alone 
is also shown (open histograms). 
was  used  to  identify  ones  that  may interact  with  pre-B 
cells. We designed the Ig/pEFBOSX vector, which directs 
production of soluble Ig fusion proteins. This vector had 
NotI and XhoI cloning sites, between the EF-lot promoter 
and coding sequences of the CH2 and CH3 domains of hu- 
man IgG1 (Fig. 2 A). Thus, cDNAs with the correct read- 
ing frame in the signal sequence-enriched library (Fig. 1 A) 
would also be able to express an Ig fusion protein when 
subcloned into the  Ig/pEFBOSX vector (Fig. 2 A).  As a 
positive control, a  construct was prepared with a  cDNA 
containing the extracellular domain and signal sequence of 
CD44 in Ig/pEFBOSX, and 2 Ixg of this plasmid was trans- 
fected to 293T cells in  24-well plates.  Supernatants  from 
the  transfectants  were  harvested on  day 5  and  found to 
contain  N10  Ixg/ml  of CD44-Ig fusion protein  (data  not 
shown).  The  sensitivity of detection  of particular  clones 
was  then  tested  by serial  dilution  experiments  in  which 
mixtures  were  made  of the  CD44-Ig/pEFBOSX  and  Ig/ 
pEFBOSX  plasmids.  Supernatants  containing  CD44-Ig 
were recognized by the ability to bind to the hyaluronan- 
bearing BMS2 stromal cell clone. This revealed that one 
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Number  of  Signal  Insert 
Molecule  clones  sequence  Extracellular  cDNA 
bp 
Biglycan  5  +  Yes  432 
Syndecan 4  2  +  Yes  306 
Collagen type 1  2  +  Yes  384 
Clusterin  1  +  Yes  264 
Osteonectin  3  +  Yes  372 
Matrix glycoprotein scl  3  +  Yes  387 
4-9 (unknown)  1  +  Yes  347 
Saposin  1  +  No  ND 
positive clone could be identified when it was diluted in a 
pool with 10 negative clones. 
We picked 900 individual colonies from the signal se- 
quence-enriched library in the Ig/pEFBOSX vector and 
made pools that each represented 10 colonies. Flow cy- 
tometry was  then used  to identify pools that  contained 
plasmids capable of expressing fusion proteins that recog- 
nized BCB10 cells (Fig. 2 B). This pre-B cell line was used 
because it can be grown in the presence of IL7 plus stem 
cell factor, and also because it has a very low level of Fc re- 
ceptor expression. A total of 18 individual clones whose Ig 
fusion proteins had  this  property were  isolated  and  se- 
quenced.  All  inserts  contained  5'  terminal  cDNA  se- 
quences, and their lengths varied from 264 to 432 bp (Ta- 
ble I). One encoded a known intracellular protein, saposin, 
and was not considered further for that reason (60). How- 
ever, this protein is heavily glycosylated and also has a hy- 
drophobic domain at the amino terminus, which presum- 
ably accounted for its selection with our method. One, 4-9, 
represented a  previously unknown molecule. The others 
corresponded to previously described components of the 
extracellular matrix (biglycan, syndecan 4, collagen type I, 
clusterin, osteonectin, and matrix glycoprotein scl) (9, 38, 
47, 49). Each of these are known to have signal sequences 
and to be either secreted or expressed on the surface of 
ceils. A murine homologue of matrix glycoprotein scl had 
not been previously cloned, and the sequence identified 
here had 80.6% identity to that described for the rat (16). 
Similarly, this represents the first isolation of murine syn- 
decan 4, which has 91.5%  identity to the rat homologue 
(19). Therefore, this cloning strategy did indeed select for 
cDNAs with signal sequences, and stromal cell molecules 
that  are  potentially relevant for interactions with pre-B 
cells were identified. 
Isolation of the 4-9 cDNA Coding Region and Primary 
Structure of the Predicted Protein 
The entire coding region of the 4-9 cDNA was isolated to 
permit more thorough homology searches and structural 
predictions. This was done with sense and antisense prim- 
ers designed from the original 5' cDNA sequence of 4-9, 
which were used to screen a stromal cell library by PCR 
(Materials and Methods). The originally isolated fragment 
of 4-9 was completely identical to the sequence between 
133 and 479 of the full-length cDNA (Fig. 3; EMBL/Gen- 
Bank/DDBJ accession number U47323). The latter 3,192- 
bp  cDNA  contains  an  open reading frame of 2,055  bp, 
which is flanked by 5'- and 3'-untranslated regions of 193 
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Figure 3.  Amino acid sequence of full-length 4-9. A potential sig- 
nal peptide is marked (box), but the actual cleavage site is un- 
known. The protein encoded by the original cDNA (underlined 
with dashes) and a possible transmembrane  domain (underlined.) 
Potential N-glycosylation sites (circles) and a possible enzymatic 
cleavage  site  (asterisks). This  sequence  data  is  available from 
EMBL/GenBank/DDBJ under accession number U47323. 
and  944 bp.  The hydrophobicity profile of the  deduced 
685-amino acid protein predicts a possible NH2-terminal 
signal peptide. This hydrophobic region precedes a possi- 
ble signal cleavage site between Ser-22 and Leu-23, as pre- 
dicted by the method of Heijne (12). A second hydropho- 
bic stretch of 22 amino acids is located between positions 
213 and 234,  and could correspond to a  transmembrane 
domain (8). The protein possesses a dibasic sequence be- 
fore this segment, which could serve as a proteolytic cleav- 
age site for release from the cell surface. There is also a 
single cysteine residue in the putative transmembrane do- 
main  that  may  allow  interaction with  other  membrane 
proteins, and there are two potential sites for N-glycosyla- 
tion at positions 131 and 171. 
A computer search revealed that segments of the 4-9 se- 
quence had been cloned before as part of genome projects, 
but this was not instructive as to its function. One previous 
isolation was from a human brain cDNA library (WashU- 
Merck EST Project, unpublished data; computation per- 
formed using the BLAST network service). Another rep- 
resented only the 3'-untranslated  region of 4-9 and was 
isolated from a murine teratocarcinoma cell cDNA library 
(46). The predicted extracellular portion of this protein 
had no significant homology to any other proteins. How- 
ever, there was weak similarity between the intracellular 
portion  of 4-9  and  human  myosin  heavy chain  (18.7% 
identity  in  a  198-amino  acid  overlap),  human  restin 
(15.2% identity in a 329-amino acid overlap), Drosophila 
melanogaster paramyosin (13.8% identity in a 441-amino 
acid overlap), and human centromeric protein E  (14.4% 
identity in a 416-amino acid overlap). A predicted coiled- 
coil structure is a common feature of all of these proteins. 
Oritani and Kincade Stromal Cell Interaction  Molecules  775 Figure 4.  Expression of stro- 
mal cell products  in various 
cells  and  tissues.  (A)  Total 
RNAs were isolated from the 
indicated cell lines and  sub- 
jected  to RT-PCR.  The am- 
plified products were electro- 
phoresed  through  a  1% 
agarose gel containing ethid- 
ium bromide.  Sequences for 
the  oligonucleotide  primers 
used for these  reactions  are 
given in Materials and Meth- 
ods. (B) eoly(A)  ÷ RNAs (2 
Ixg per lane)  were from  the 
indicated tissues, and the re- 
sulting  blot  was  hybridized 
overnight to a probe contain- 
ing the  entire 4-9 cDNA se- 
quence. (Lower panel) Con- 
trol for equal loading where 
the  same  blot  was  probed 
with 13-actin. 
Expression of  Stromal Cell Products in Various Tissues 
Our  cloning  strategy  should  not  necessarily  select  for 
genes that are expressed in a stromal cell-restricted fash- 
ion,  and,  indeed,  this  was  not  the  case.  Reverse  tran- 
scriptase-PCR was used to survey expression by a panel of 
cell lines (Fig. 4 A), and the specificity of these reactions 
was confirmed by sequencing of the PCR products (data 
not shown). This analysis revealed that two of the genes 
we cloned (syndecan 4, 4-9) were expressed by many cell 
types, which included lymphomas and myeloid tumors, but 
not a mastocytoma (P815). Transcripts for the 4-9, but not 
syndecan 4 gene, were also detectable in an erythroleuke- 
mia cell line (GM86). Clusterin and osteonectin were each 
expressed by stromal cells and some lympho-hematopoi- 
etic cells. A  more restricted pattern was observed with bi- 
glycan, collagen type I, and matrix scl, as transcripts were 
only detectable in stromal cells and fibroblasts. Northern 
blot analysis confirmed that the previously unknown 4-9 
gene is expressed in many tissues, but that there was some 
heterogeneity in transcript size (Fig. 4 B). The most prom- 
inent band was ~4.5 kb, but shorter and longer exposures 
consistently revealed minor species that were larger  (9.5 
and 5 kb) and smaller (3.7 kb). 
Distribution of  Ligands for Soluble Stromal 
Cell-derived Fusion Proteins 
Experiments were then performed to evaluate interactions 
of stromal cell-derived fusion proteins with various types 
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Ig fusion proteins 
Cell type  Cell line  Biglycan  4-9  Syndecan 4  Coll. 1  Clusterin  Scl  Osteonectin 
PreB  BCB10  ++  +  ++  ++  +  -  + 
Pre B  BCB8  +  -+  +  +  +  -  -+  - 
Pre B  BCB9  +  +  +  +  +  +  +  +  ±  + 
B  Lymphoma  WEHI231  +  +  -  +  +  .... 
B  Hybridoma  BM2  -  -  ±  .... 
T  Lymphoma  EIA  ....... 
T  Lymphoma  AKR1  ....... 
Myeloid  WEHI3  -  ±  ±  +  +  -+  ± 
Erythroleukemia  GM86  +  +  +  +  -  -  -  + 
Stromal  OP42  +  -  +  .... 
Stromal  BMS2  +  -  ±  .... 
Fibroblast  L  Cells  +  -  ±  .... 
Neuroblastoma  N2A  +  -  4-  .... 
Melanoma  B 16F  10  +  -  +  .... 
++,  >90%; +, >50%; -+, >10%; and -,  <10% of cens staining. 
of lympho-hematopoietic cells. Two steps were taken to 
minimize the possibility of recognition via Fc receptors. 
All of the soluble proteins were made with a human IgG1 
cassette that had been mutated to diminish Fc-mediated 
binding (37) (see Materials and Methods), and in some ex- 
periments, cells were pretreated with an mAb (2.4G2) to 
Fc receptors. The latter treatment had no influence on fu- 
sion protein staining of BCB10 cells, but did slightly re- 
duce the background recognition of CD11b + myeloid cells 
(data  not  shown).  An  example  of  recognition  of  the 
BCB10 pre-B cell clone is illustrated in Fig. 2 B, where a 
CD44-Ig fusion protein is included as a negative control. 
Similar levels of background staining were observed when 
human CD73-Ig or CD7-Ig were used as control proteins 
(data  not  shown).  The intensity of staining  was  consis- 
tently strongest with biglycan and syndecan 4 fusion pro- 
teins. Recognition of two other B lineage lymphocyte pre- 
cursor  clones  (BCB8  and  BCB9)  was  similar  to  that 
observed with BCB10, and two of the fusion proteins gave 
low, but significant, staining when tested on an immature 
B  lymphoma (WEHI231; Table II). In contrast, none of 
the fusion proteins recognized either of two T lymphomas 
(AKR1  and EIA). Biglycan and syndecan 4  fusion pro- 
teins weakly stained a number of cell types, but recogni- 
tion was very limited with the other fusion proteins. 
Conditions for Recognition of Normal 
Lympho-hematopoietic Cells 
Divalent cations facilitated recognition of BCB10 cells by 
fusion proteins prepared with 4-9, biglycan, collagen type I, 
clusterin,  matrix  glycoprotein  scl,  and  osteonectin,  as 
staining  was  completely blocked by addition  of EDTA 
(Fig. 5 A; data not shown). This treatment also slightly di- 
minished staining with the syndecan 4-Ig fusion protein 
(data not shown). It has been shown that Mn ++ substan- 
tially increases the ability of integrins to recognize ligands 
(39). We found that recognition of pre-B cells with 4-9 and 
osteonectin also increased with this treatment (Fig. 5 A; 
data not shown). Antibodies to et4 (PS/2), et5 (MFRS), et6 
(GoH3), OtL (FD441.8 and M17/4.2), 131(KMI6 and 9EG7), 
or  [32  (M18/2)  did  not  block  the  binding  of 4-9-Ig  to 
BCB10 cells (data not shown). Moreover, 4-9-Ig did not 
recognize BAF3 cells even in the presence of Mn  ++, al- 
though  this  line  expresses  VLA4,  VLA5,  VLA6,  and 
CD11a  (data  not  shown).  Thus,  the  counter-receptor/ 
ligand for 4-9 on BCB10 cells was not readily attributed to 
any of these  integrins.  Addition  of heparin  significantly 
blocked staining by the 4-9 fusion protein, a finding that 
could also be instructive about its counter-receptor. 
All of the above studies used lympho-hematopoietic tu- 
mors and cultured cell lines. Therefore, we used two-color 
flow cytometry to evaluate the ability of the 4-9-Ig fusion 
protein to interact with freshly isolated bone marrow cells 
(Fig. 5 B). This protein bound to 51% of marrow cells, and 
68%  of the  positive  cells  also  expressed the  B  lineage 
marker  CD45R.  Only weak  staining  was  observed with 
~8%  of bone marrow-nucleated cells using the  control 
CD44-Ig fusion protein, and these did not represent B lin- 
eage cells. The ability of lymphocyte precursors to interact 
with  4-9  appeared  to  increase  with  differentiation,  and 
78% of cells that had acquired sIgM (B cells) were stained 
by this fusion protein. Similarly, 88% of mature B cells in 
the spleen were recognized (data not shown). While the 
4-9 fusion protein recognized lymphocytes and their pre- 
cursors in marrow, it was not lineage specific, as 9-36% of 
myeloid cells (assessed with Ly-6C/GR1 or CD11b/Mac-1, 
respectively) and 55% of erythroid cells (TER119  ÷) were 
stained.  In addition, 20%  of splenic T  cells were recog- 
nized (data not shown). These analyses were performed in 
the presence of Mn ++, and, as with cell lines, failure to add 
this  divalent  cation  resulted  in  much  weaker  staining. 
These findings suggest that a counter-receptor/ligand for 
the 4-9 stromal cell product is present on normal hemato- 
poietic cells and may increase in density with B  lympho- 
cyte differentiation. 
Influence of Stromal Cell Products on B Cell Precursors 
Production of B lineage lymphocytes is dependent on IL7, 
and numbers of IL7-responsive precursors can be enumer- 
ated with  a  semisolid agar cloning assay  (29). This was 
used in a preliminary evaluation of possible functions for 
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Figure 5.  The 4-9-Ig fusion protein recognizes normal cells, and 
the  binding  requires  divalent  cations.  (A)  BCB10  cells  were 
stained with the 4-9-Ig fusion protein (right) in the presence of 
Hank's  solution  (1.3  mM  Ca ++,  0.9  mM  Mg÷+),  Hanks  with 
EDTA (5 mM), Tris buffer with Mn +÷ (5 mM), Tris buffer with 
both Mn +÷ and chondroitin sulfate (C.S.,  5 ixg/ml), or Tris buffer 
with both Mn ÷  ÷ and heparin (5 I.~g/ml). Background staining with 
the second antibody alone is also shown (right; Negative Control), 
along with staining obtained with a control CD44-Ig fusion pro- 
tein (left). (B) Two-color analysis of bone marrow included mark- 
ers of B  lineage lymphoid cells  (CD45R and surface IgM) and 
myeloid cells  (Macl/CDllb).  Quadrants  are indicated  to show 
levels  of background staining (obtained with irrelevant isotype- 
matched antibody or second antibody alone controls). Staining 
and washing were done in the presence of 5 mM MnC12. 
the  molecules  we  identified.  Soluble  Ig  fusion  proteins 
representing  CD44,  syndecan 4,  osteonectin,  or collagen 
type I  had no significant effect on lymphocyte prolifera- 
tion when added to these cultures (Fig. 6; data not shown). 
However, the cloning efficiency was increased upon addi- 
tion  of biglycan-, scl-,  or 4-9-containing fusion proteins. 
This  ranged from 23-76%  elevation  in six individual  ex- 
periments,  and was similar for the original version of 4-9 
and a fusion protein that contained the entire extracellular 
sequence.  None of the proteins  elicited colony formation 
when  added  to semisolid  agar cultures in the  absence  of 
IL7 (data not shown). As little as 2 tzg of the 4-9-Ig fusion 
protein influenced clonal proliferation of B cell precursors 
(P =  0.0015; Fig. 6). Similar dose responsiveness was dem- 
onstrated with biglycan and scl, but 10 times this amount 
Figure 6.  Dose-dependent augmentation of B cell precursor ex- 
pansion by Ig fusion proteins.  Biglycan-Ig, 4-9-Ig, scl-Ig, and 
CD44-Ig proteins were purified on protein A columns and added 
to CFU-IL7 colony assays  at the indicated concentrations. Re- 
suits represent mean numbers of colonies per 105 cultured cells --_ 
SEM  (n  =  3).  Statistically  significant  differences  from control 
(CD44-Ig) values  are indicated by one (P ~< 0.05) or two (P ~< 
0.01) asterisks. 
of the control CD44-Ig fusion protein had no significant 
effect.  Myeloid  progenitors  (CFU-c)  that  responded  to 
colony stimulating factor were not significantly influenced 
by any of the Ig fusion proteins  (data not shown). There- 
fore,  some of the stromal cell-derived  products promote 
expansion of IL7-responsive lymphocyte precursors. 
Morphological Changes Resulting from Overexpression 
of the 4-9 Protein 
No remarkable  changes were  observed  in  the  growth or 
appearance  of 293T  cells  transfected  with  the  originally 
isolated  4-9 cDNA  (14%  of the  total  sequence  plus  the 
epitope tag and transmembrane  domain of tissue factor). 
This  was  also  true  when  the  entire  extracellular  portion 
was overexpressed  with  the  tissue  factor transmembrane 
domain  (data  not shown).  However,  cells  expressing  the 
full-length sequence assumed a  rounded morphology and 
detached from the dish within 2 d  of transfection (Fig. 7). 
Since the change occurred before confluence was reached, 
it did not result from overgrowth of contact-inhibited cells. 
While numbers of cells recovered 3-4 d  after transfection 
with this plasmid were slightly reduced, there was no effect 
on  cell  viability.  This  result  suggests  that  the  native  4-9 
protein may have roles in adhesion and/or cell shape that 
require the transmembrane and/or cytoplasmic domains. 
Discussion 
We have described  a  new cloning strategy and its  use  to 
identify a  series  of stromal cell genes whose products in- 
teract with pre-B cells. An enrichment procedure was de- 
vised  for cDNAs that  encode  type  I  transmembrane  or 
secreted  proteins  with signal peptides.  A  second step  in- 
volved expression of the resulting library as soluble Ig fu- 
sion proteins and screening for ones that recognized lym- 
phocytes.  While  there  are  advantages  and  limitations  to 
any approach,  this  one  was  successfully  used  to  identify 
The Journal of Cell Biology,  Volume 134, 1996  778 Figure 7.  Rounding  and detachment of 293T cells after overex- 
pression  of the full-length cDNA of 4-9. Phase-contrast  micro- 
graphs are shown of 293T cells transfected with pEFBOS (control 
plasmid) (A) or the full-length native 4-9/pEFBOS (B). Bar, 50 ixm. 
several  components  of the  bone  marrow  microenviron- 
ment  that  may  prove  to  be  important  in  regulation  of 
blood cell formation. 
Honjo and colleagues reported that it was possible to se- 
lectively clone cDNAs corresponding to secreted or trans- 
membrane molecules (59). As in their method, we incor- 
porated  an  epitope  sequence  in  the  expression  vector. 
However, we then expressed the resulting library in COS 
cells and used an mAb to the epitope tag with cell sorting 
to enrich for cDNAs that included signal sequences. We 
used COS cells and electroporation at this stage with the 
aim of obtaining relatively low copy numbers in the trans- 
fected cells. There are two indications that this enrichment 
step was successful. Transfection of the same amount of 
plasmid DNA yielded progressively higher expression of 
the epitope tag after the three cycles of sorting (Fig. 1 B). 
Secondly, clones of interest were relatively abundant  in 
the enriched library, as 1.8% of the clones yielded an Ig fu- 
sion protein that recognized pre-B cells. In preliminary ex- 
periments, we determined that a pool size of no more than 
10 clones per pool was  required  to  detect binding  of a 
CD44-Ig  control  protein  to  a  hyaluronan-bearing  cell. 
Therefore, we doubt that it would have been feasible to 
search for relevant molecules expressed as Ig fusion pro- 
teins without prior enrichment of the library for cDNAs 
that encode signal sequences. 
Our objective in screening Ig fusion proteins expressed 
by the stromal cell library was to identify important mole- 
cules that might have been overlooked by other experi- 
mental approaches. For example, highly conserved cell in- 
teraction molecules might not be immunogenic, making 
it difficult to produce mAbs  against  them. Also, screens 
based on cell adhesion could require relatively high avidity 
binding or cooperation between multiple molecules. Our 
procedure yields sequences for individual molecules with 
potentially interesting recognition properties, and the nec- 
essary threshold of binding affinity could be lower than with 
other methods. It produces soluble cell interaction mole- 
cules with defined recognition specificity that can be used 
in functional and other assays. The binding can also pro- 
vide useful information about the nature of the counter- 
receptor (e.g., requirement for divalent cations, blocking 
by heparin) and its representation in various tissues. Fur- 
thermore, this method is readily adaptable to detect other 
kinds of cell interaction molecules. For example, we could 
screen the same enriched library for proteins that specifi- 
cally recognize hematopoietic stem cells. In principal, any 
pair of interacting cells could be used to derive cDNA li- 
braries and for screening in either direction. We selected 
stromal cells for library preparation rather than lympho- 
cytes because  staining of the latter was  more efficiently 
evaluated by flow cytometry. 
A  relatively small  insert  size  (~400  bp)  was  used  to 
avoid the possibility that transmembrane domains would 
be cloned 5' of the epitope tag. Therefore, we would not 
have identified proteins whose entire length is required for 
function, and  it  is  notable  that  no cytokine genes  were 
cloned.  We  subsequently obtained  full-length  (or entire 
extracellular portions) cDNA sequences for three of the 
clones (4-9, syndecan 4, and osteonectin). When expressed 
as Ig fusion proteins, they recognized pre-B cells as well as 
the original ones, which only contained partial sequences. 
Therefore, we may have preferentially identified proteins 
whose amino-terminal portions were sufficient for binding 
to pre-B cells. Similarly, this method would not isolate mole- 
cules that only function as part  of complexes. Transfec- 
tants were prepared that initially contained plasmids rep- 
resenting ~10 clones, and this would produce a number of 
heterodimeric Ig fusion proteins. These might have lower 
affinity than homodimers, and detection of relatively abun- 
dant proteins could be favored. On the other hand, the en- 
richment  achieved  with  the  first  step  of  our  approach 
should at least partially diminish this as a problem. As an- 
other possible  limitation,  posttranslational  modifications 
of molecules  expressed  in  293T  cells  might  differ from 
those typical of stromal cells. We would not have identi- 
fied proteins whose recognition specificity was influenced 
in this way. 
All but one of the stromal cell products we identified 
have been previously studied,  and  there  are  indications 
that some of these molecules may participate in lympho- 
hemopoiesis. For example, an inhibitor of collagen synthe- 
sis diminished production of hematopoietic cells in long-term 
bone marrow cultures (64). Multiple collagen types can be 
made by bone marrow stromal cells, and precursors of my- 
eloid and erythroid cells have been shown to adhere to 
collagen type I  (27, 62). There are four known types of 
syndecan, and they are known to be expressed in a tissue- 
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present  on pre-B  cells,  down-regulated  as  they mature, 
and reacquired at the plasma cell stage (53). This molecule 
has  been  shown  to  mediate  adhesion  of plasmacytoma 
cells to collagen type I (54), but we do not yet know if it is 
involved in pre-B cell recognition of stromal cell-derived 
collagen. Overexpresssion of syndecans 1 and 4 in B lym- 
phoid cells can trigger aggregation, suggesting again that 
these molecules may be involved in cell recognition (57). 
Osteonectin  has  also  been  implicated  in  cell  adhesion. 
While osteonectin can mediate the aggregation of plate- 
lets, it can be antiadhesive in other circumstances (28). Os- 
teonectin is detectable in a granular pattern on adherent 
cells in long-term bone marrow cultures (34). 
Biglycan was previously isolated from the thymus and 
shown  to  function  as  a  macrophage  colony-stimulating 
factor (17). Only 91 of the amino-terminal residues of bi- 
glycan (N25% of the molecule) were present in our Ig fu- 
sion protein, and this did not stimulate growth of myeloid 
progenitors in culture. However, the same material signifi- 
cantly enhanced the cloning of IL7-responsive precursors 
in semisolid agar. The same was true of Ig fusion proteins 
containing segments of matrix glycoprotein scl or the 4-9 
clone. Further study will be required to determine if en- 
gagement of ligands on pre-B cells by these stromal cell 
molecules delivers costimulatory signals for survival and 
differentiation. Alternatively, they might block reception 
of negative signals  that could be present in  the FCS  or 
made by neighboring ceils. In this context, it is interesting 
that 4-9 is actually expressed by pre-B cells and could me- 
diate interaction between cells in the same lineage. 
Syndecan and  biglycan are  known  to  be  heparan-  or 
chrondroitin/dermatan-sulfated proteoglycans. These modi- 
fications may contribute to cell-cell recognition and could 
also confer on these molecules the ability to immobilize 
growth  and  differentiation  factors.  Heparin  has  been 
shown to block cell adhesion mediated by syndecan (57). 
Similarly, we found that staining of pre-B cells by our 4-9-Ig, 
syndecan 4-Ig, and biglycan-Ig fusion proteins was sub- 
stantially inhibited by addition of heparin (Fig. 5 A; un- 
published  observations).  Glycosaminoglycan recognition 
is a feature of certain other cell adhesion molecules, such 
as N-cell adhesion molecule (N-CAM) and CD31  (6, 7). 
Furthermore, this modification is essential for responsive- 
ness of cells to basic FGF (48). Heparan-sulfated proteins 
can  influence  the  differentiation of hematopoietic cells 
(36), and this may be in part attributed to their ability to 
immobilize  growth  factors  such  as  granulocyte-macro- 
phage  colony stimulating  factor (G/M-CSF),  IL-3, basic 
FGF, IL7, and interferon-y (3,  11, 21,  35,  51).  All three 
members  of the  decorin family, including  biglycan,  are 
known to bind TGF-I3, but glycosylation is not necessary 
(13).  Osteonectin is not a  proteoglycan, but it has been 
shown to immobilize PGDF (28). It will be important to 
determine if the  stromal cell--derived molecules we  iso- 
lated bind growth and differentiation factors, as this would 
suggest  another role in the  bone marrow microenviron- 
ment. 
At least 16 names have been used to describe the mole- 
cule known as clusterin, and a similarly large number of 
functions have been ascribed to it (52). It is an abundant 
and widely distributed protein that is especially rich in tis- 
sues undergoing remodeling and where apoptosis is high, 
but not directly involved in that process (10). Clusterin has 
a  heparin-binding domain and has been shown to cause 
aggregation of Sertoli cells (for review see 52). The ability 
of clusterin to bind Ig is of particular interest (63). Matur- 
ing pre-B cells make a primitive Ig-receptor complex con- 
sisting  of ~  heavy chains  with  "surrogate"  light  chains 
(Vpre-B and hs), and gene targeting revealed this is essen- 
tial for normal lymphocyte formation (41, 25). It has been 
speculated that the Ig complex recognizes some ligand on 
stromal cells (41), and clusterin would seem to be a candi- 
date. 
Our findings suggest that 4-9 is a type I transmembrane 
protein with a functional signal peptide. There is a stretch 
of 22 hydrophobic residues  that might serve as  a  trans- 
membrane anchor, but this remains to be verified. There is 
a potential enzyme cleavage site (RH) near this area, sug- 
gesting that portions of the molecule might be released as 
a soluble protein. Another stretch of residues (TRHNHL) 
in the same region conform to a heparin-binding consen- 
sus motif (XBBXBX), where B represents a basic residue 
and X a hydropathic residue (4). The presumed intracellu- 
lar portion of 4- 9 has weak sequence homology to myosin 
heavy chain and related proteins that have a  coiled-coil 
structure. 
Northern blot and PCR analyses revealed that the gene 
is expressed in a number of tissues and in most cell lines. 
While we have shown that 4-9 can influence the survival 
and/or proliferation of B cell precursors, it also recognized 
most mature splenic B cells and a subpopulation of T cells, 
provided that Mn +÷ was present in the medium. There- 
fore, the biological function may not be restricted to mar- 
row, and it will be important to learn if it has a role in im- 
mune responses.  Additional work must  also be done to 
identify the  ligand  recognized by 4-9.  Staining  of pre-B 
cells with the Ig fusion protein was divalent cation--depen- 
dent and markedly enhanced  by Mn  +÷.  It is  interesting 
that the specificity, as well as the affinity, of integrins is in- 
fluenced by divalent cations (24, 39). One could speculate 
that while 4-9 expression is relatively broad, its function 
may be locally controlled in this fashion. However, our 
preliminary experiments did not positively identify an in- 
tegrin (VLA4, VLA5, VLA6, or CDlla) as the ligand for 
4-9 on pre-B cells. Cadherins, selectins, and other divalent 
cation-dependent recognition molecules must also be con- 
sidered. 
Expression of extracellular portions of 4-9 in 293T cells 
as  either membrane-anchored or secreted forms had no 
noticeable influence on morphology or cell growth. How- 
ever, considerable rounding and detachment of the cells 
resulted  from  expression  of  the  full-length  molecule. 
Therefore, normal functions of the native protein in stro- 
mal ceils may depend on both intracellular and extracellu- 
lar domains. This dramatic change in morphology of cells 
that  overexpress 4-9 suggests  that it may help to orient 
stromal cells within tissues. It will be important to learn if 
4-9  associates  with  cytoskeletal or other components of 
the cell, and we provisionally designate it SIM (stromal in- 
teraction molecule). 
A first application of this new cloning strategy led to the 
identification  of seven  extracellular  proteins  that  merit 
further study as components of lympho-hematopoietic mi- 
The Journal of Cell Biology, Volume 134, 1996  780 croenvironments. Ig fusion proteins containing only por- 
tions of three such stromal products  augmented the re- 
sponsiveness of pre-B cells to IL7. Native versions of these 
molecules may be found to participate in adhesive interac- 
tions, deliver critical signals, or immobilize and present 
growth factors to maturing blood cells. 
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